TruthArchive.ai - Related Video Feed

It is claimed that ethical concerns prevent double-blind placebo trials for childhood vaccines already on the schedule that never underwent safety testing. The first step should be honesty about the clinical trial data underlying childhood vaccines. One proposed method involves comparing health outcomes of vaccinated versus unvaccinated individuals using existing datasets. If unvaccinated children are equally or less healthy than vaccinated children, this should be published to reassure parents. However, if vaccinated children are less healthy, the claim that these products cannot harm anyone should be reconsidered. It is asserted that comparative studies between vaccinated and unvaccinated individuals have been conducted, but not published because they allegedly show that the unvaccinated are healthier. Publishing a study showing vaccinated individuals are healthier would have discredited Robert Kennedy Jr., but the fact that it wasn't published suggests a problem.

In 2011 the IOM issued a vaccine-safety report, 'Adverse Effects of Evidence of Causality,' examining 158 serious injuries after vaccination. The speaker notes they were consulting for Sanofi, Merck, GSK, and others, not disclosed in the report. Tdap is on the childhood schedule and is given to pregnant women. On autism, the IOM concluded, 'The evidence is inadequate to accept or reject a causal relationship between diphtheria toxoid, tetanus toxoid, or acellular pertussis containing vaccine and autism.' The evidence doesn't exist to show whether DTaP or Tdap do or do not cause autism. 'There is not evidence to, say a million different things. We have no suspicions, at least I don't, that, autism is caused by DTaP.' 'absence of evidence is no proof whatsoever.' He could tell parents that DTaP, Tdap does not cause autism, and, 'I'm also willing to tell them it doesn't cause leprosy.'

According to the speaker, most vaccines have never been tested in a randomized, placebo-controlled trial to evaluate their safety. The speaker claims that vaccines contain aluminum compounds because many dead vaccines don't mount an immune response without them. The speaker alleges that in a Gardasil vaccine study, the placebo group received an aluminum adjuvant instead of a true placebo, resulting in similar side effect profiles between the active vaccine and placebo groups. The speaker asserts that Merck used a novel aluminum compound and that data suggests aluminum in vaccines is profoundly toxic. The speaker states that the only true randomized controlled trial involving a vaccine was conducted on sheep with blue tongue disease. The results allegedly showed that the aluminum in the vaccine was toxic, causing the sheep to become sick, unsociable, and, in some cases, die. The speaker concludes that the assumption that aluminum adjuvants in vaccines are safe is unfounded and has never been tested.

Vaccine recommendations typically come from the Advisory Committee of Immunization Practices (an outside consulting committee at CDC) and VRBPAC (within FDA), which recommends vaccine licensure. These committees only adopted evidence-based medicine about twelve years ago. The speaker states that during their administration, they want safety studies prior to vaccine licensure and recommendation. They claim vaccines are exempt from pre-licensing safety testing, and the COVID vaccine was the only one tested in a full placebo trial. They assert that the other 76 shots children receive between birth and 18 have not been safety tested against a placebo, meaning the risk profile is not understood. The speaker intends to remedy this.

The speaker claims that no double-blind, placebo-controlled safety trials have been conducted on any childhood vaccines currently on the market. The speaker states that they have searched for such trials and been unable to find any. According to the speaker, Anthony Fauci and Francis Collins allegedly admitted that placebo-controlled safety trials are not performed on childhood vaccines because it would be unethical to test products administered to children. The speaker challenges news agencies to provide evidence of a double-blind, placebo-controlled trial done prior to licensure for any childhood vaccine, asserting that it doesn't exist.

None of the 72 vaccines for children have been tested against a placebo. The speaker sued HHS in 2016 to find placebo studies for vaccines, but none were found. The safety testing for the polio vaccine was only 48 hours, while the hepatitis b vaccines were tested for 4-5 days. This means that any adverse events occurring after that time period were not considered. Without placebo testing, the risk profile of current vaccines is unknown, and it cannot be determined if vaccines cause more harm than good. The speaker questions the ethics of mandating medical products with unknown risks for children.

The speakers discuss the need for careful preclinical studies before licensing vaccines. They mention that large studies covering different age groups are necessary, but these data often come out later after the vaccine has been used in thousands or millions of people. The conversation then focuses on whether DTaP or Tdap vaccines cause autism. The Institute of Medicine (IOM) concludes that the evidence is inadequate to accept or reject a causal relationship between these vaccines and autism. While there are no studies showing a link, one study by anti-vaccination figures is mentioned, but it lacks legitimacy. The speakers emphasize the absence of positive evidence and the importance of administering vaccines to children. They also mention that there are no complaints about DTaP causing leprosy. The IOM's scientific review was conducted due to complaints about vaccines causing autism. Despite the lack of conclusive evidence, the pediatrician is willing to tell parents that vaccines do not cause autism or leprosy because they prioritize the child's health. The IOM did not review whether DTaP causes sleep issues.

We couldn't find any prelicensing safety trials for the 72 vaccines doses that are recommended for American children. Unlike other medications, vaccines were exempt from conducting safety trials that compare health outcomes between a placebo group and a vaccine group. This lack of safety trials is concerning considering the widespread use of these vaccines.

The childhood vaccine schedule is managed by a vaccine advisory group with CDC and American Academy of Pediatrics representation. Changes would come to my desk for review, but this committee is very influential in vaccine policy. Regarding the hepatitis B vaccine, I'm surprised it's given to day-old babies based on limited safety data from a study with only a five-day review period and no placebo group. The FDA likely extrapolated adult data, but I don't think this establishes safety for newborns. I would prefer to see this vaccine given to older children. I disagree with the heavy-handed approach to vaccines, as it increases hesitancy and distrust. Doctors should educate, not badger or threaten, people about vaccines. I'm not a big advocate for one-year-olds getting the hepatitis B vaccine unless the mother is hepatitis B positive and the baby is at high risk.

The documentary follows a growing concern: the rise of chronic illness and neurodevelopmental disorders in American children, with speakers outlining striking statistics, personal stories, and contested science around vaccines. Key facts and patterns: - A shift from decades ago to today: more than forty percent of American children now have at least one chronic health condition; estimates cited include that over fifty-four percent of kids have a chronic disease, up from twelve point eight percent in the 1980s. One speaker emphasizes that in forty years there has been “the greatest decline in human health ever recorded.” - Autism rates have surged: just a few decades ago, one in ten thousand children had autism; today, one in thirty-one. Other listed conditions include ADD/ADHD, tics/Tourette’s, narcolepsy, sleep disorders, IBS, autoimmune diseases (rheumatoid arthritis, juvenile diabetes, lupus, Crohn’s), eczema, asthma, seizures, and various neurological issues. - The central question raised: what is causing this epidemic of chronic illness in kids? The film argues that rapid increases in incidence cannot be explained by genetic change alone, which would take generations. Story and study arc: - The narrative centers on a scientist who was willing to conduct a study into vaccine safety and vaccine injury, but who faced career-risking consequences when attempting to publish or disseminate results. - The film’s narrator and investigators say they compiled hidden-camera testimonies, interviews, and raw stories from parents whose children experienced serious adverse events after vaccines (eczema, seizures, chronic GI issues, sleep apnea, language loss, autonomic and neurological symptoms, and death in some cases). Stories include a child who lost language after vaccination, triplets who regressed into severe autism after their pneumococcal shot, and families describing chronic, ongoing medical crises following vaccines. - The film frames a broader debate: vaccines are safe and effective, with extensive global use and long-standing public health endorsement. Yet it argues that the vaccine safety narrative lacks certain types of trials, particularly double-blind placebo-controlled trials for childhood vaccines. It claims that, in some cases, no such trials exist prior to licensure, and that post-licensure safety surveillance is limited or incomplete. Vaccine safety testing and regulatory claims: - The film argues that none of the 72 vaccine doses on the childhood schedule has ever been subjected to a pre-licensure double-blind placebo-controlled trial, which is presented as the gold standard of safety testing. It asserts that safety assessments and post-licensure surveillance often rely on observational data rather than randomized trials. - A critical example is the hepatitis B vaccine (Recombivax HB): the FDA-approved trial cited shows safety monitoring for only five days after each dose, with no placebo control. The film argues this is insufficient to detect autoimmune or neurodevelopmental issues that could emerge years later. - Dr. Stanley Plotkin, a leading vaccine expert, is interviewed regarding whether five days of safety monitoring captures potential autoimmune or neurological adverse events; the dialogue suggests concern about the adequacy of such safety windows and controls. - The documentary presents the notion that the absence of a placebo-controlled vaccine safety trial is used to argue safety, while retrospective studies and unblinded cohort analyses hints at potential signals that would merit more rigorous testing. Henry Ford Health System and the “vaccinated vs unvaccinated” study: - Dell and others pursue a vaccinated-versus-unvaccinated study using Henry Ford Health System data, with the aim of comparing health outcomes in vaccinated and unvaccinated children. They argue that this kind of retrospective cohort study can reveal safety signals when randomized trials are unavailable. - The study reportedly found that vaccination exposure was associated with higher risks of several chronic conditions, including asthma, atopic diseases, autoimmune diseases (e.g., rheumatoid arthritis, SLE, Guillain-Barré syndrome), and neurodevelopmental disorders. They summarize that by ten years, 57% of vaccinated children had a chronic health condition versus 17% of unvaccinated children; overall, two to four times higher risks across several categories were reported, with notable differences in neurodevelopmental outcomes. - The study reportedly found zero chronic conditions in the unvaccinated group for several categories, though the vaccinated group showed higher incidence in many categories. Autism did not reach statistical significance in this study due to small numbers. The presenters emphasize that retrospective studies have limitations (confounding, follow-up length, healthcare-seeking behavior), but argue that the signal deserves publication and replication. - The Henry Ford study reportedly faced professional and institutional barriers: a threat of defamation, failed attempts to publish, and internal resistance. The documentary showcases a dinner meeting where Dr. Marcus Zervos expresses willingness to publish but ultimately faces career risk, leading to discussions about “Galileo moments” and whether data should be released despite pushback. Industry and public health responses: - The film juxtaposes the public health consensus—vaccines save lives, the schedule is well tested, and billions of people have been studied—with dissenting voices from physicians, scientists, and parents who argue that independent, large-scale vaccinated-versus-unvaccinated analyses are necessary to truly assess safety outcomes. - It includes testimonials from doctors who faced professional pushback after expressing concerns about broader vaccine safety questions or demonstrating adverse effects in patient populations. - The documentary frames a call to replicate the retrospective study in other large health systems (e.g., Kaiser Permanente, Harvard Pilgrim, CDC’s VSD) to determine whether the Henry Ford findings hold across populations, and whether impaired health outcomes correlate with the breadth of vaccination exposure. Conclusion and call to action: - The film asserts that if the data are valid, this would constitute a sea-change in our understanding of off-target and nonspecific effects of vaccination and would necessitate reconsidering how the vaccination program is designed and implemented. - Viewers are urged to consider the evidence, demand replication, and reflect on the moral and ethical implications of vaccine safety research, balancing public health benefits with potential risks, and exploring alternate strategies to protect child health.

We couldn't find a prelicensing safety trial for any of the 72 vaccines doses recommended for American children. Unlike other medications, vaccines were exempt from conducting safety trials that compare health outcomes between a placebo group and a vaccine group.

In 2007 trial, the placebo contained a toxic agent, affecting the comparison between vaccine and control groups. Both groups had 3% new autoimmune conditions, but it was dismissed. The lack of questioning raises concerns about vaccine safety. Comparing the 3% to general population rates would be logical. Individuals like Julie Gerberding and Peter Marks, who have ties to big pharma, may overlook such issues. Gerberding's move from CDC director to Merck's vaccines president with a $4,000,000 bonus raises ethical questions.

Big problem with trusting the science is not the science part, it's who's behind the science part, primarily in the area of vaccines for children. Normally, when you study a drug, you compare it with a placebo, so that way you can truly test the side effects on something, but that is not how they test children's vaccines. This so called placebo control is not really a true placebo control because it's not inert. It's an active vaccine with something called an adjuvant. The big one that they've been using for a long time is aluminum. My question is, how can you really truly test the safety and effectiveness of something if you're looking at the relative safety of an active vaccine to another active vaccine with adjuvants. That just muddies the water to this whole safe and effective claim that you keep hearing over and over and over.

The speakers discuss the need for careful preclinical studies before licensing vaccines. They mention that large studies covering different age groups are necessary, but these data often come later after the vaccine has been used in thousands or millions of people. The conversation then focuses on whether DTaP or Tdap vaccines cause autism. The Institute of Medicine (IOM) concludes that the evidence is inadequate to accept or reject a causal relationship between these vaccines and autism. While there are no studies showing a link, one study by anti-vaccination figures is mentioned, but it lacks legitimacy. The speakers emphasize that there is no positive evidence to disprove the link. However, as a physician, one speaker states that vaccines do not cause autism and that they prioritize the health of the child over waiting for conclusive scientific evidence. The discussion also briefly mentions the possibility of DTaP causing leprosy, although there are no complaints about it. The IOM's review did not cover this topic.

Vaccines are neither safe, effective, necessary, nor harmless, and this has been a two-hundred-year indoctrination. No vaccine has ever been proven safe because true placebos aren't used, and subjects aren't followed long enough. Safety is determined by whether the vaccine causes immediate death. Long-term effects like asthma, allergies, eczema, ADD, ADHD, neurological problems, and autoimmune diseases are not monitored. The FDA arbitrarily decided in the early 1990s that side effects appearing more than 72 hours after vaccination are unrelated.

The speaker states they searched for years for a pre-licensing safety trial of the 72 vaccine doses effectively mandated for American children. They claim that every other medication requires a safety trial comparing health outcomes in a placebo group versus a vaccine group before FDA licensing. The speaker assumed this was also done for vaccines. They state they found out that vaccines were exempt from this requirement.

Dr. Plotkin testified that there are two hepatitis B vaccines on the market: Engerix B by Glaxo and Recombivax HB by Merck. The clinical trial experience for Recombivax HB states that safety was monitored for only 5 days after each dose, which may not be long enough to detect autoimmune or neurological issues. There is no mention of a control group in the clinical trials. The manufacturer insert also reports hypersensitivity reactions, arthritis, autoimmune diseases, and nervous system disorders like Guillain Barre syndrome and multiple sclerosis after vaccination. However, no randomized placebo-controlled study was conducted before licensure. It would be ethically difficult to conduct such a study today, even though the vaccine is recommended by the CDC.

"There is not one longitudinal safety study on hepatitis b against unvaccinated kids versus vaccinated kids, inert placebo, does not exist." "The two studies that are cited most often, one is for MMR." "Hep B is not involved." "They're like, we did a huge study about this. No autism." "And I'm not suggesting there's a link. I'm simply saying that huge study is only MMR." "The other study they love to talk about involves thimerosal." "Not everything else about the hepatitis B vaccine." "There the there the reality is it's not settled science. Just it's okay." "Vaccines have like, we could but to even say that, anti vaxxer."

The speakers discuss adverse reactions listed in Section 6.2 of a vaccine's package circular. They mention hypersensitive reactions, autoimmune diseases, nervous system disorders, and other conditions. The first speaker emphasizes that the presence of these reactions in the circular does not prove causation. The second speaker brings up the 2011 IOM report, which did not establish a causal relationship between the vaccine and multiple sclerosis. They discuss the need for a randomized, placebo-controlled study to determine causation. The second speaker questions the length of the safety review period for another hepatitis B vaccine and requests proof of any post-administration reactions. The presence of a control group in the trial is also discussed.

The transcript follows a documentary-style examination of rising chronic illness in American children and a contested view of vaccine safety and testing. It weaves together personal testimonies, investigative reporting, and expert interviews to present a narrative that vaccines may be linked to widespread health problems and that the safety science behind vaccination is insufficient or flawed in certain respects. Key claims about child health trends - A diverse set of pediatric health issues is described as increasingly common: ADHD, allergies, eczema, psoriasis, autoimmune diseases (rheumatoid arthritis, juvenile diabetes, lupus, Crohn’s disease), IBS, sleep disorders, seizures, and neurological conditions. Several speakers list multiple conditions affecting children, suggesting a broad chronic disease trend. - A striking statistic cited: “More than forty percent of American children now have at least one chronic health condition” (Speaker 5). Relatedly, autism rates are described as rising from “one in ten thousand” decades ago to “one in thirty one” today (Speaker 5). - An overarching contention is that these rapid increases are unlikely to be explained by genetics alone, given the relatively fast pace of change in incidence. The central study and the “hidden” narrative - The documentary frames a study led by a scientist who allegedly conducted research into chronic disease and vaccination but chose not to publish due to fear of repercussions. Hidden-camera investigations and interviews are used to explore why such data might remain unpublished and how the medical establishment responds to dissenting findings. - The film positions Dr. Zervos (Marcus Zervos), an infectious disease expert at Henry Ford Health System, as a pivotal figure who agreed to a vaccinated-versus-unvaccinated study but reportedly did not publish the results, leading the filmmakers to pursue further inquiry with him and others. Vaccines, safety testing, and the placebo question - A core claim is that vaccines have not undergone the gold standard of safety testing: double-blind, randomized, placebo-controlled trials for the entire childhood schedule. The film argues that no childhood vaccine has completed such a trial prior to licensure. - The hepatitis B vaccine (Recombivax HB) is used as an example: its pre-licensure safety data reportedly cover only five days after each dose, with no long-term control group, and section 6.1 of the insert notes five days of safety monitoring, raising questions about detecting longer-term autoimmune or neurological injuries. - Opposing voices acknowledge ethical constraints around placebo trials in the presence of existing vaccines, but the documentary challenges this by pointing out that certain comparator trials (e.g., Prevnar 13 vs Prevnar 7) were not against saline placebo, and thus do not establish a safety baseline. - A recurring metaphor is the “whiskey study” scenario to illustrate how non-saline placebo comparisons can mislead safety conclusions. Retrospective and observational studies; the vaccine-safety signal - The film emphasizes retrospective and observational studies as alternatives to randomized trials, arguing they can reveal safety signals when prospective trials are unavailable. It highlights the Henry Ford Health System’s data as a major retrospective study: a vaccinated-versus-unvaccinated analysis based on a large, integrated health database. - According to the film, the Henry Ford study found that vaccinated children had higher risks across multiple chronic health categories. Specifically, ten years of follow-up suggested: - Vaccinated children were 2.5 times more likely to have a chronic health condition overall. - An approximate fourfold increased risk for chronic health conditions in certain analyses. - A 4.29-times higher risk for autism was not statistically significant due to small autism counts in the unvaccinated group, but substantial signals were observed in other neurodevelopmental outcomes. - The study reported markedly higher rates of autoimmune diseases (around six times higher) and various neurodevelopmental disorders in the vaccinated group compared with unvaccinated peers. - In the ten-year window, 57% of vaccinated children had a chronic health condition versus 17% of unvaccinated children. - The documentary notes methodological limitations common to retrospective studies, such as follow-up differences and confounding factors, but argues that sensitivity analyses did not overturn the main findings. The vaccine schedule, broader policy, and dissent within the medical community - The narrative asserts that a large portion of physicians publicly defend vaccines as safe and effective, with long-standing support for vaccination policies and mandates. Yet it also recounts stories of physicians who faced professional pushback, licensing actions, or public criticism after raising questions about vaccine safety or suggesting alternative research paths. - The film mentions the Institute of Medicine’s 2011 report, which stated that there were over 150 injuries likely associated with vaccines that had not been studied, and it notes that no large, randomized comparisons between fully vaccinated and fully unvaccinated populations had been published by major institutions (as of the report’s release). - The filmmakers recount efforts to obtain a definitive vaccination–unvaccinated study from Henry Ford and other institutions, with some figures expressing willingness to publish if the study clearly demonstrated that unvaccinated children fared better, while others face professional or political pressures. Vaccine advocacy versus safety concerns; the call for replication - Pro-vaccine voices in the film emphasize that vaccines have prevented millions of deaths and remain broadly safe, citing the historical success of vaccines and the large body of published research supporting vaccine effectiveness and safety. - Proponents of re-examination advocate replicating retrospective cohort analyses in other large health systems (e.g., Kaiser Permanente, Harvard Pilgrim, CDC’s VSD) to test whether similar patterns emerge. They stress the ethical and scientific necessity of replication to determine whether the observed signals hold across populations. - The film closes with a call for replication and transparency: if the data are robust, publishing them could transform the understanding of off-target and non-specific effects of vaccination. If replicated, such studies could reshape how vaccines are administered and studied. The documentary also threads personal stories of vaccine injury, including cases of severe reactions after various vaccines and the emotional and logistical toll on families. It juxtaposes these individual tragedies with the broader debate over vaccine safety research, urging readers to consider the evidence, replication, and the possibility that current vaccine safety paradigms may require reassessment.

According to the speaker, vaccines have never been tested in a randomized, placebo-controlled trial to evaluate their safety. The speaker claims that vaccines contain aluminum compounds because many dead vaccines don't mount an immune response without them. The speaker alleges that in a Gardasil vaccine study, the placebo group received an aluminum adjuvant instead of a true placebo, so the side effect profiles of the active vaccine and placebo groups were the same. The speaker asserts that Merck used a novel aluminum compound and that data shows aluminum in vaccines is toxic. The speaker states that the only completely randomized controlled trial was on sheep using a vaccine for blue tongue disease. The speaker claims the aluminum was toxic, the sheep became sick, their behavior changed, and many died compared to the placebo group. The speaker concludes that the presumption that aluminum as an adjuvant is safe is unfounded and has never been tested.

Speaker 0 questions Speaker 1 about the lack of clinical trial data for the MMR vaccine. Speaker 1 insists that the vaccine was extensively tested before being licensed and that millions of doses have been used. Speaker 0 asks for proof of pre-licensure clinical trials, but Speaker 1 only refers to a book and mentions studies done in the 1960s. Speaker 0 argues that the data provided is not sufficient and questions the absence of a placebo group. Speaker 1 admits uncertainty about the inclusion of control groups but maintains that safety assessments were conducted. Speaker 0 concludes that no randomized placebo-controlled study exists for the MMR vaccine. Speaker 1 agrees to provide additional information after the deposition.

None of the vaccines, including the COVID vaccine, have undergone proper testing. No childhood vaccine has completed a placebo-controlled clinical trial with sufficient duration and power to confirm its safety before being administered to millions of children in America. This is not an opinion; it can be verified by anyone visiting the FDA website, where the package inserts and clinical trial documents are available for review.

Exhibit 22 is an excerpt from the IOM's report discussing whether DTaP or TDaP cause autism. The IOM concluded that there is inadequate evidence to determine a causal relationship. Speaker 1 points out that there are no studies showing that vaccines cause autism, except for one study by Guyer and Guyer, who lack legitimacy. They emphasize the need for a proper study involving controlled administration of vaccines. Speaker 1, as a physician, cannot definitively say vaccines do not cause autism, but they believe they do not. Speaker 0 questions if it is appropriate to make that claim without scientific evidence. Speaker 1 argues that they prioritize the child's health and are willing to say vaccines do not cause autism. The IOM did not review if DTaP causes leprosy.